A groundbreaking study has revealed that a simple urine test may help identify autism spectrum disorder (ASD) in children earlier and more accurately than many current assessment methods. Scientists found that children with autism often have unique metabolic signatures linked to gut microorganisms, opening the door to a potentially faster and more objective screening tool.
The findings, recently published in Molecular Psychiatry, suggest that biological markers found in urine could help healthcare providers identify children at high risk for autism years before traditional behavioral evaluations provide clear answers.
Autism spectrum disorder is typically diagnosed through behavioral observations, developmental assessments, and parent interviews. While these methods are valuable, diagnosis can sometimes take years, particularly in children with subtle symptoms.
Early identification is important because it allows families to access interventions, therapies, and educational support sooner. Research has consistently shown that children who receive early support often experience better developmental outcomes in communication, learning, and social interaction.
However, many families face lengthy waiting periods before receiving a diagnosis. This delay can create uncertainty and postpone access to critical resources.
The newly developed urine test could help reduce that gap.
Researchers from Arizona State University examined urine samples from 52 children diagnosed with autism and compared them with samples from 47 neurotypical children.
The team focused on metabolites, which are chemical compounds produced when gut microbes process nutrients and other substances. These metabolites can provide valuable insights into biological processes occurring throughout the body.
The study revealed a striking pattern. Many children with autism showed unusually high levels of specific metabolites that were either absent or significantly lower in children without autism.
According to the researchers, approximately 80% to 90% of autistic children displayed elevated levels of one or more microbial metabolites.
Some of these compounds were measured at levels 100 to 1,000 times higher than those observed in the control group.
One of the most significant findings involved metabolites related to serotonin and dopamine pathways.
Serotonin and dopamine are neurotransmitters that play essential roles in:
Researchers noted that gut bacteria appear to produce altered versions of compounds associated with these neurotransmitters.
This connection could help explain why many autistic individuals experience challenges related to social communication, anxiety, depression, and attention.
The study also identified metabolites linked to amino acids such as:
These amino acids are crucial building blocks in neurotransmitter production and brain function.
Additionally, certain compounds appeared to be associated with yeast and fungal activity within the gut microbiome.
Using data collected during the study, scientists developed a screening model based on 17 specific metabolites found in urine samples from children aged 2 to 11 years.
The results were encouraging.
Researchers reported that the test correctly identified approximately 90% of children with autism. Furthermore, none of the children without autism were incorrectly classified as autistic in the study sample.
While these findings are promising, experts caution that larger studies are needed before the test can be widely used in clinical settings.
Additional validation across different populations and age groups will help determine whether the test maintains its accuracy in broader real-world applications.
Current autism evaluations rely heavily on behavioral observations conducted by trained professionals. While effective, these assessments can be subjective and may vary depending on the evaluator's experience.
A biological screening tool could offer several advantages:
Healthcare providers may be able to identify children who need further evaluation much earlier.
Biological markers provide measurable data that can complement behavioral assessments.
Children identified at higher risk could access support services sooner.
Parents may gain additional information during the often lengthy diagnostic process.
Researchers hope the test will eventually serve as a screening aid rather than a replacement for comprehensive clinical evaluations.
The study adds to a growing body of evidence linking gut health and neurological development.
Scientists increasingly recognize that the gut microbiome influences many aspects of human health beyond digestion. Through the gut-brain axis, microorganisms living in the digestive tract can affect immune function, metabolism, neurotransmitter production, and even behavior.
The elevated metabolites identified in autistic children may reflect disruptions in this complex communication system.
While researchers are still investigating the exact mechanisms involved, the findings suggest that gut microbial activity could play a meaningful role in autism-related biology.
Beyond diagnosis, the discovery may help guide future treatment strategies.
If certain gut microbes contribute to the production of problematic metabolites, therapies aimed at modifying the microbiome could potentially offer benefits.
Areas of future research may include:
Scientists emphasize that these approaches require extensive research before any conclusions can be drawn regarding effectiveness or safety.
Researchers also hope that biological evidence associated with autism may help reduce misconceptions surrounding the condition.
Many parents experience anxiety, guilt, or uncertainty while seeking answers about their child's development. A biologically based screening tool may reinforce the understanding that autism is a neurodevelopmental condition influenced by complex biological factors rather than parenting style or family environment.
Improved awareness and earlier identification could encourage more families to seek evaluations and support without hesitation.
Although the findings are exciting, experts stress that the urine test remains in the research stage.
Future studies involving larger and more diverse populations will be necessary to confirm the results. Researchers must also determine how well the test performs across different ethnic groups, geographical regions, and varying autism presentations.
If validated through additional research, this approach could become a valuable addition to existing autism screening and diagnostic tools.
For families waiting for answers, even modest reductions in diagnostic delays could have a meaningful impact on access to support and intervention services.
The discovery of autism-related metabolic markers in urine represents a potentially important step forward in autism research. By analyzing compounds produced by gut microbes, scientists have developed a test that demonstrated impressive accuracy in an early study.
While more research is needed before clinical adoption, the findings highlight the growing importance of the gut-brain connection and offer hope for earlier autism detection in the future.
As researchers continue to explore the biological foundations of autism, innovative screening methods like this urine test may help families receive answers, support, and intervention sooner than ever before.
Flynn C., Adams J., et al. Research findings published in Molecular Psychiatry and Arizona State University news release (May 26, 2026).
This article is intended for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. The research discussed is preliminary and requires further validation before widespread clinical use. Always consult a qualified healthcare professional regarding concerns about autism, developmental conditions, or any medical decisions involving a child. Individual health circumstances vary, and findings from scientific studies may not apply to every person.
Most Accurate Healthcare AI designed for everything from admin workflows to clinical decision support.